Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingnot_applicable

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

NCT07536516
recruitingnot_applicable

Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects

NCT03870230
recruiting

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

NCT05650905

Clinical Trials (3)

Showing 3 of 3 trials
NCT07536516Not Applicable

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

Recruiting
NCT03870230Not Applicable

Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects

Recruiting
NCT05650905

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3